A pharmacokinetic study of edoxaban in patients with breast cancer using the P-glycoprotein inhibitor tamoxifen
Latest Information Update: 09 Aug 2021
At a glance
- Drugs Edoxaban (Primary)
- Indications Thrombosis; Venous thromboembolism
- Focus Pharmacokinetics
- Acronyms PHIX-IT
Most Recent Events
- 01 Aug 2021 Planned End Date changed from 1 Aug 2020 to 30 Sep 2021.
- 06 Aug 2019 New trial record